000851774 001__ 851774
000851774 005__ 20220930130157.0
000851774 0247_ $$2doi$$a10.1074/jbc.RA118.003116
000851774 0247_ $$2ISSN$$a0021-9258
000851774 0247_ $$2ISSN$$a1083-351X
000851774 0247_ $$2Handle$$a2128/19847
000851774 0247_ $$2pmid$$apmid:30131337
000851774 0247_ $$2WOS$$aWOS:000447256000001
000851774 0247_ $$2altmetric$$aaltmetric:49720363
000851774 037__ $$aFZJ-2018-05289
000851774 082__ $$a570
000851774 1001_ $$0P:(DE-Juel1)161275$$aRösener, Nadine$$b0$$ufzj
000851774 245__ $$aA D-enantiomeric peptide interferes with hetero-association of amyloid-β oligomers and prion protein
000851774 260__ $$aBethesda, Md.$$bSoc.$$c2018
000851774 3367_ $$2DRIVER$$aarticle
000851774 3367_ $$2DataCite$$aOutput Types/Journal article
000851774 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1540303232_18558
000851774 3367_ $$2BibTeX$$aARTICLE
000851774 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000851774 3367_ $$00$$2EndNote$$aJournal Article
000851774 520__ $$aAlzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. One AD hallmark is the aggregation of amyloid-β (Aβ) into soluble oligomers and insoluble fibrils. Several studies have reported that oligomers rather than fibrils are the most toxic species in AD progression. Aβ oligomers bind with high affinity to membrane-associated prion protein (PrP), leading to toxic signaling across the cell membrane, which makes the Aβ–PrP interaction an attractive therapeutic target. Here, probing this interaction in more detail, we found that both full-length, soluble human (hu) PrP(23–230) and huPrP(23–144), lacking the globular C-terminal domain, bind to Aβ oligomers to form large complexes above the megadalton size range. Following purification by sucrose density–gradient ultracentrifugation, the Aβ and huPrP contents in these hetero-assemblies were quantified by reversed-phase HPLC. The Aβ:PrP molar ratio in these assemblies exhibited some limited variation depending on the molar ratio of the initial mixture. Specifically, a molar ratio of about four Aβ to one huPrP in the presence of an excess of huPrP(23–230) or huPrP(23–144) suggested that four Aβ units are required to form one huPrP-binding site. Of note, an Aβ-binding all-D-enantiomeric peptide, RD2D3, competed with huPrP for Aβ oligomers and interfered with Aβ–PrP hetero-assembly in a concentration-dependent manner. Our results highlight the importance of multivalent epitopes on Aβ oligomers for Aβ–PrP interactions and have yielded an all-D-peptide-based, therapeutically promising agent that competes with PrP for these interactions.
000851774 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000851774 588__ $$aDataset connected to CrossRef
000851774 7001_ $$0P:(DE-Juel1)145165$$aGremer, Lothar$$b1$$ufzj
000851774 7001_ $$0P:(DE-HGF)0$$aReinartz, Elke$$b2
000851774 7001_ $$0P:(DE-Juel1)165994$$aKönig, Anna$$b3$$ufzj
000851774 7001_ $$0P:(DE-HGF)0$$aBrener, Oleksandr$$b4
000851774 7001_ $$0P:(DE-Juel1)132002$$aHeise, Henrike$$b5$$ufzj
000851774 7001_ $$0P:(DE-Juel1)166306$$aHoyer, Wolfgang$$b6$$ufzj
000851774 7001_ $$0P:(DE-Juel1)144510$$aNeudecker, Philipp$$b7$$ufzj
000851774 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b8$$eCorresponding author$$ufzj
000851774 773__ $$0PERI:(DE-600)1474604-9$$a10.1074/jbc.RA118.003116$$gp. jbc.RA118.003116 -$$pjbc.RA118.003116 -$$tThe journal of biological chemistry$$v293$$x1083-351X$$y2018
000851774 8564_ $$uhttps://juser.fz-juelich.de/record/851774/files/2018-09-13_Willbold.pdf
000851774 8564_ $$uhttps://juser.fz-juelich.de/record/851774/files/2018-09-13_Willbold.pdf?subformat=pdfa$$xpdfa
000851774 8564_ $$uhttps://juser.fz-juelich.de/record/851774/files/J.%20Biol.%20Chem.-2018-R%C3%B6sener-15748-64-1.pdf$$yPublished on 2018-08-21. Available in OpenAccess from 2019-08-21.
000851774 8564_ $$uhttps://juser.fz-juelich.de/record/851774/files/J.%20Biol.%20Chem.-2018-R%C3%B6sener-15748-64-1.pdf?subformat=pdfa$$xpdfa$$yPublished on 2018-08-21. Available in OpenAccess from 2019-08-21.
000851774 8767_ $$894233761$$92018-09-13$$d2018-09-13$$ePage charges$$jZahlung erfolgt$$pRA003116$$z1785 USD
000851774 909CO $$ooai:juser.fz-juelich.de:851774$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)161275$$aForschungszentrum Jülich$$b0$$kFZJ
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145165$$aForschungszentrum Jülich$$b1$$kFZJ
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)165994$$aForschungszentrum Jülich$$b3$$kFZJ
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-HGF)0$$aForschungszentrum Jülich$$b4$$kFZJ
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132002$$aForschungszentrum Jülich$$b5$$kFZJ
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166306$$aForschungszentrum Jülich$$b6$$kFZJ
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)144510$$aForschungszentrum Jülich$$b7$$kFZJ
000851774 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b8$$kFZJ
000851774 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000851774 9141_ $$y2018
000851774 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000851774 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000851774 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000851774 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000851774 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ BIOL CHEM : 2015
000851774 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000851774 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000851774 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000851774 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000851774 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000851774 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000851774 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000851774 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000851774 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000851774 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000851774 9801_ $$aAPC
000851774 9801_ $$aFullTexts
000851774 980__ $$ajournal
000851774 980__ $$aVDB
000851774 980__ $$aUNRESTRICTED
000851774 980__ $$aI:(DE-Juel1)ICS-6-20110106
000851774 980__ $$aAPC
000851774 981__ $$aI:(DE-Juel1)IBI-7-20200312